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1. Structures of key compounds used in this study 
 
 
 
MeNV-HaXS (top): 
1-(4-((24-chloro-3,6,9,12,15,18-hexaoxatetracosyl)oxy)-5-methoxy-2-nitrophenyl)ethyl (4-(((2-amino-
9H-purin-6-yl)oxy)methyl)benzyl)carbamate 
 
HaXS8 (bottom): 
N-(4-(((2-amino-9H-purin-6-yl)oxy)methyl)benzyl)-2-(4-((18-chloro-3,6,9,12-tetraoxaoctadecyl)oxy)-
2,3,5,6-tetrafluorophenoxy)acetamide (see reference [16] in main text). 
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2. Supplementary experimental procedures and conditions 
 
Chemical synthesis and characterization 
 MeNV-HaXS was synthesized in 8 steps starting from acetovanillone, hexaethylene glycol, 
O6-aminomethylbenzylguanine and 6-chloro-1-iodohexane with good overall yield (>800 mg 
produced). To balance cell permeability and solubility in water, a PEG6 element was introduced. The 
methyl-6-nitroveratryl group (MeNV) was selected as a photocleavable group because it absorbs light 
at >360 nm. This minimizes cell damage, matches initiation of photocleavage to widely available 
excitation equipment and filters, and MeNV provides a sufficient quantum yield for intracellular 
photocleavage. Last but not least, intermediates and by-products emerging from the photolytic 
process do not interfere with living cells. The photophysical properties of MeNV-HaXS were 
determined in vitro as described below. MeNV-HaXS is not sensitive to ambient light, displays 
excellent cleavage efficiency at 360 nm with an absorption coefficient of 4058 M-1cm-1, and a quantum 
yield of 0.075. No special precautions concerning light exposure were required during synthesis. 
 
 Materials and reagents were of the highest commercially available grade and used without 
further purification. Reactions were monitored by thin layer chromatography (TLC) using Merck silica 
gel 60 F254 plates. Compounds were visualized by UV, ceric ammonium molybdate (CAM), KMnO4 
and ninhydrin. Flash chromatography was performed using Merck silica gel 60, particle size 40 - 63 
μm. 
 
 1H, 19F and 13C NMR spectra were recorded on a Bruker AV-400 or a DRX-600 NMR 
spectrometer. Chemical shifts are reported in ppm using the solvent residue signals as reference. All 
solvents used for reactions were purchased as anhydrous grade from Fluka. Solvents for extractions, 
flash chromatography and TLC were commercial grade. Mass spectra were recorded with a VG70-
250  (FAB), Finnigan MAT MS 312 (EI) or Finnigan MAT LCQ (ESI) spectrometer. High resolution 
mass spectra were recorded with a Thermo Fisher Scientific LTQ Orbitrap XL, nanoelectrospray ion 
source.  
 
Measurement of the absorption spectra 
 UV/Vis spectra of 10-5 M solution of MeNV-HaXS in DMSO was recorded on a Perkin Elmer 
Lambda 40 UV/Vis spectrometer using quartz standard absorption cells. The extinction coefficients 
were calculated for 360 nm. 
 
 The emission of the transilluminator lamps (RPR-3500 Å, RPR-3600 Å and RPR-4190 Å) was 
recorded with an AVA SPEC 2048 spectrometer. With the same spectrometer an absorption spectrum 
of the glass cover slip was recorded to verify that there is no absorbance in the irradiation 
wavelengths range. 
 
General procedure for the analysis of photolysis 
 The irradiated solution was transferred into an HPLC microvial and injected into an Aquity H-
Class UPLC system equipped with an ESI-SQD mass spectrometer. The photolysis yield was 
determined by integration of the Single Ion Monitoring (SIM) signal of the starting product. 
 
Protein denaturation, cell lysis and immune-blotting 
 Cells were washed with ice cold PBS and lysed in a NP-40 lysis buffer [1% NP-40, 20 mM 
Tris-HCl pH 8.0, 138 mM NaCl, 2.7 mM KCl, 5% glycerol, 40 mM NaF, 2 mM Na3VO4, 20 μM 
Leupeptin, 18 μM Pepstatin, 5 μM Aprotinin, 1 mM PMSF, 1 mM MgCl2, 1 mM CaCl2, 5 mM EDTA]. 
Cell lysates were cleared by centrifugation at 13’000 rpm for 15 min and proteins were denatured by 
the addition of 5x sample buffer [312.5 mM Tris-HCl (pH 6.8), 10% SDS, 25% β-mercaptoethanol, 
50% glycerol, bromphenol blue] and cooking for 6 min. Proteins were separated by SDS-PAGE and 
transferred to Immobilon PVDF membranes (Millipore). Mouse monoclonal antibody (mAb) to GFP 
(Roche Diagnostics) was used to detect GFP-fusion proteins. Secondary antibodies labeled with 
horseradish peroxidase (HRP-conjugated goat anti-mouse IgG) were visualized using enhanced 
chemiluminescence (Millipore) and a CCD camera (Fusion Fx7, Vilber). 
 
Cloning of expression constructs 
The HaloTag7 L273Y coding sequence (Promega) and SNAPf coding sequence (kind gift from K. 
Johnsson, Lausanne), mTFP1 (kind gift of O. Pertz, Basel), Golgi targeting sequence Giantin 
(kind gift from T. Inoue, Baltimore), LAMP1 (kind gift from T. Inoue, Baltimore), plasma 
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membrane targeting sequence CAAX (kind gift of J, Downward, London) and mTq (kind gift of 
J. Goedhart Amsterdam) were amplified by PCR (Phusion polymerase, Finnzymes).  
For HaloTag L273Y L273Y-GFP, HaloTag7 L273Y-RFP, and SNAPf-GFP expression constructs, 
HaloTag7 L273Y and SNAPf were transferred to pEGFP (Clonetech), or pTag-RFP-N1 
(Evrogen) expression vectors. 
SNAPf-mTFP1: GFP was exchanged in a SNAPf-GFP plasmid by the mTFP1 sequence. 
HaloTag7 L273Y-RFP-Giantin: the Giantin targeting sequence was introduced into the HaloTag7 
L273Y-RFP expression vector. 
NLS-CFP-SNAP: FKBP1x from the NLS-CFP-FKBP1x expression vector (kind gift from S. Hübner, 
Würzburg) was exchanged by the SNAPf sequence. 
HaloTag7 L273Y-RFP-Rheb15: HaloTag7 L273Y-RFP was amplified by PCR and fused to a Rheb15 
sequence to be inserted into the pTag-RFP-N1 backbone with RFP was excised. 
Halo-RFP-Rheb15: HA-Raptor was replaced by HaloTag7 L273Y-RFP in a HA-Raptor-Rheb15 
expression vector kindly obtained from Anna Melone. 
LAMP-RFP-HaloTag7 L273Y: the LAMP1 targeting sequence was inserted into the RFP-HaloTag7 
L273Y expression vector. 
Mito-SYFP-SNAPf: FRB was exchanged into a Mito-SYFP-FRB expression construct (kind gift of P. 
Scheiffele, Basel) by the SNAPf sequence. 
LifeAct-mTFP1-SNAPf: mTFP1 was fused to LifeAct by PCR, and inserted into the GFP-SNAPf 
expression construct (were GFP was excised). 
HaloTag7 L273Y-mTq: GFP was exchanged by the mTq sequence. 
 Maps and expression vector sequences can be obtained from the authors upon request. 
 
Statistical Analysis 
 Statistical analysis was performed with GraphPad Prism v6. For Student’s t test (two sided, 
non-paired with Welch correction, p < 0.05) ≥3 independent experiments were compared. 
 
Cell culture and transfection 
 HeLa cells (ATCC) were cultured in complete Dulbeccos’s modified Eagle medium (DMEM) 
with 10% heat-inactivated fetal calf serum (HIFCS), 2 mM L-glutamine (Gln), 1% penicillin-
streptomycin solution (PEST) at 37°C and 5% CO2. Transfections were carried out with JetPEI 
(Brunschwig) according to manufacturer’s guidelines. 
 
Cellular heterodimerization and intracellular cleavage 
 HeLa cells were grown in 6-well cell culture plates (Falcon), and were transfected with 
expression constructs for SNAP-GFP, Halo-GFP, Halo-RFP-Giantin, SNAP-mTFP1 or NLS-CFP-
SNAP. After 24 h, cells were exposed to MeNV-HaXS or HaXS8 dimerizer as described in complete 
cell culture medium (at 37°C). Before bulk photocleavage experiments, cells were washed twice in 1 x 
PBS after treatment with HaXS8 or MeNV-HaXS. Then 600 μl 1x PBS was added to each well, and 
the cell cells in the culture plate on ice was illuminated for 10 min with a high-intensity UV lamp (Blak-
Ray B-100A high intensity UV lamp; 100 Watt, 365 nm, UVP) at a distance of 5 cm. 
For Western Blot analysis, cells were lysed, and proteins were separated by SDS-PAGE. SNAP/Halo-
tag dimers were detected using anti-GFP (primary) and horseradish peroxidase (HRP)-conjugated 
(secondary) antibodies to visualize dimer formation using enhanced chemiluminescence (Millipore) 
and a CCD camera (Fusion Fx7, Vilber). 
 For live cell microscopy, transfected and MeNV-HaXS resp. HaXS8 treated cells grown on 12 
mm cover slips (Menzel) were mounted in Ludin chambers (Live Imaging Services) in the closed 
confirmation with complete cell culture medium without phenol red. Pictures were taken every 1 
seconds before illumination of the cells and every 1 sec for Figure 3 resp. every 15 sec for Figure 4. 
Images were acquired on a Leica Live Imaging Microscope fitted with a HCX Plan-Fluotar 63x/1.4 oil 
objective and a Photometrics CCD Camera CoolSnap HQ2 with Metamorph 7.1 software (Molecular 
devices). Cleavage in Fig. 3a and 3b and Fig. 4a was performed with a 50 mW FRAP scanning laser 
(UV-Diode Laser, 355 nm, 30 Hz). Single spots within the indicated region of interest where irradiated 
for the indicated times. For photocleavage experiments as shown in Fig. 3d, standard DAPI excitation 
filters were used on a Leica EL600 microscope (equipped with a mercury metal halide lamp; filter 
cube: ex: 377±25 nm, em: 447±30 nm, dichrioic mirror: 409 nm; 63x objective: 63xHCX Plan-Fluotar, 
NA: 1.25 [oil]). 
 Movies were assembled and analyzed with Fiji (ImageJA, 1.44b). In Figure 3a mTFP1 
fluorescence at vesicles was calculated according to the formula mTFP1 = F(mTFP1, vesicle) / 
F(RFP, whole cell) - F(mTFP1, cytoplasm) / F(RFP, whole cell) for every frame. In Figure 3b mTPF1 
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fluorescence in the cytoplasm was calculated according to the formula mTFP1 = F(mTFP1, vesicle) / 
F(RFP, whole cell). In Figure 4 CFP fluorescence at vesicles was calculated according to the formula 
CFP = F(CFP, vesicle) / F(RFP, whole cell) - F(CFP, cytoplasm) / F(RFP, whole cell) for every frame. 
Nuclear CFP fluorescence intensity was calculated according to the formula CFP = F(CFP, nucleus) / 
F(RFP, whole cell) for every image. To illustrate the fluorescence decrease from vesicles and to 
measure fluorescence increase in the cytoplasm or nucleus, mTFP1 or CFP fluorescence intensity 
was plotted over time. 
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3. Chemical synthesis and characterization of compounds 
 
 
Synthesis of MeNV-HaXS 
 
 
 
 
Reaction conditions: a) NaH, 6-chloro-1-iodohexane, THF/DMF, 0°C, 16 h; b) PPh3, CBr4, rt, 16 h; c) K2CO3, benzyl bromide, 
DMF, 80°C, 16 h; d) Acetic acid, acetic anhydride, HNO3, rt, 16 h; e) Acetic acid, HBr, 85°C, 1.5 h; f) K2CO3, 3, DMF, 60°C, 16 
h; g) NaBH4, MeOH/Dioxane, rt, 2 h; h) bis p-nitrophenyl carbonate, triethylamine, DMF, rt, 16 h; i) O6-
aminomethylbenzylguanine, 60°C, 6 h. 
 
Scheme S1. Synthetic route to MeNV-HaXS. 
 
 
Preparation of 24-chloro-3,6,9,12,15,18-hexaoxatetracosan-1-ol (2) 
 Hexaethyleneglycol (1) (2.1 mL, 8.4 mmol) was dissolved in a THF/DMF mixture (3:1). 
Sodium hydride (60% in mineral oil, 370 mg, 9.2 mmol) was added portionwise at 0 °C. After stirring 
for 30 min at rt, 6-chloro-1-iodohexane (6.4 mL, 8.4 mmol) was added dropwise at 0 °C. The mixture 
was stirred at rt for 16 h. The excess of sodium hydride was carefully quenched with water and the 
crude mixture was poured into water and extracted twice with AcOEt. The combined organic layers 
were dried over Na2SO4 and concentrated under reduced pressure. The crude oil was purified by 
flash chromatography (CH2Cl2/MeOH, 20:1) to yield compound 2 (5.3 g, 54%). 1H NMR (400 MHz, 
CD3OD): δ 3.66 - 3.61 (m, 18H), 3.58 – 3.54 (m, 6H), 3.47 (t, J = 6.80 Hz, 2H), 3.30 (m, 2H), 1.77 (m, 
2H), 1.58 (m, 2H), 1.50-1.38 (m, 4H); 13C NMR (100.6 MHz, CD3OD): δ 73.6, 72.1, 71.6, 71.5, 
71.5,71.4, 71.1, 62.2, 45.7, 33.7, 30.5, 27.7, 26.5.  
 
 
Preparation of 1-bromo-24-chloro-3,6,9,12,15,18-hexaoxatetracosane (3) 
 24-chloro-3,6,9,12,15,18-hexaoxatetracosan-1-ol 2 (950 mg, 2.37 mmol) was dissolved in 
THF. Triphenylphosphine (721 mg, 2.76 mmol) and carbon tetrabromide (900 mg, 2.76 mmol) were 
added portionwise at 0°C. The resulting mixture was stirred at rt for 16 h. The solvent is evaporated 
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under reduced pressure and the crude oil is purified by flash chromatography (cyclohexane/EtOAc, 
3:1) to yield compound 3 (800 mg, 73%). 1H NMR (400 MHz, CD3OD): δ 3.80 (t, J = 6.02 Hz, 2H), 
3.66-3.61 (m, 18H), 3.58-3.54 (m, 4H), 3.51 (t, J = 6.04 Hz, 2H), 3.48 (t, J = 6.52), 1.77 (m, 2H), 1.58 
(m, 2H), 1.36-1.52 (m, 4H); 13C NMR (100.6 MHz, CD3OD): δ 72.3, 72.1, 71.6, 71.4, 71.2, 45.7, 33.8, 
31.4, 30.6, 27.7, 26.5.  
 
 
Preparation of 1-(4-(benzyloxy)-3-methoxyphenyl)ethanone (5) 
 Acetovanillone (4) (5 g, 30.1 mmol) and benzylbromide (5.15 g, 30.1 mmol) were dissolved in 
50 mL DMF. K2CO3 (4.15 g, 30.1 mmol) was added and the mixture was stirred at 80°C for 16 h. The 
reaction was quenched with sat. NH4Cl (2 L) and extracted with AcOEt three times. The combined 
organic layers were dried over Na2SO4 and concentrated under reduced pressure. The resulting 
product 5 (6.5 g, 84%) was used without further purification. 1H NMR (400 MHz, CDCl3): δ 7.48 (d, J = 
2.01 Hz, 1H), 7.43 (dd, J = 8.26 Hz, 2.01 Hz, 1H), 7.36 (d, J = 7.23 Hz, 2H), 7.31 (td, J = 7.23 Hz, 
1.54 Hz, 2H), 7.25 (m, 2H), 6.82 (d, J = 8.26 Hz, 1H), 5.16 (s, 2H), 3.88 (s, 3H), 2.47 (s, 3H); 13C NMR 
(100.6 MHz, CDCl3): δ 196.9, 152.5, 149.6, 136.4, 130.8, 128.7, 128.1, 127.2, 123.1, 112.2, 110.5, 
70.8, 56.1, 26.2; HRMS C16H17O3 [M+H]+ calcd: 257.1172, found: 257.1166. 
 
 
Preparation of 1-(4-(benzyloxy)-5-methoxy-2-nitrophenyl)ethanone (6) 
 Nitric acid (1.4 mL, 69%) was added dropwise to a solution of o-benzylacetovanillone (5) (1.5 
g, 5.8 mmol) in acetic acid (4.9 mL) and acetic anhydride (1.4 mL) at 0°C. The mixture was stirred at 
rt overnight. The reaction was poured into ice water and extracted with AcOEt three times. The 
combined organic layers were washed with saturated NaHCO3, brine and dried over Na2SO4. The 
solvent was evaporated under reduced pressure and the crude product was purified by flash 
chromatography (cyclohexane/EtOAc 4:1) to yield the desired product 6 (718 mg, 40%). 1H NMR (400 
MHz, CDCl3) : δ 7.67 (s, 1H), 7.46-7.29- (m, 5H), 6.77 (s, 1H), 5.22 (s, 2H), 3.98 (s, 3H), 2.49 (s, 3H); 
13C NMR (100.6 MHz, CDCl3): δ 200.1, 154.6, 148.6, 138.3, 135.3, 133.1, 128.9, 128.6, 127.6, 108.8, 
71.4, 56.7, 30.4; HRMS C16H16O5N [M+H]+ calcd: 302.1023, found: 302.1017. 
 
Preparation of 1-(4-hydroxy-5-methoxy-2-nitrophenyl)ethanone (7) 
 6-Nitro-o-benzylacetovanillone (6) (4.3 g, 14.3 mmol) was dissolved in acetic acid (30 mL, 
99%), and heated to 85°C. HBr (15 mL, 48%) was added to the mixture and stirred for 1.5 h. The 
mixture was poured into ice water and extracted with AcOEt three times. The combined organic layers 
were washed with saturated NaHCO3, brine and dried over Na2SO4. The solvent was evaporated 
under reduced pressure. The crude product was purified by flash chromatography 
(cyclohexane/EtOAc, 2:1) to yield the desired compound 7 (1.1 g, 37%). 1H NMR (400 MHz, CDCl3): δ 
9.76 (s, 1H), 7.60 (s, 1H), 6.81 (s, 1H), 3.98 (s, 3H), 2.48 (s, 3H); 13C NMR (100.6 MHz, CDCl3): δ 
199.7, 152.3, 147.8, 138.8, 130.4, 110.8, 108.8, 56.2, 29.9; HRMS C9H10O5N [M+H]+ calcd: 212.0553, 
found: 212.0553. 
 
 
Preparation of 1-(4-((24-chloro-3,6,9,12,15,18-hexaoxatetracosyl)oxy)-5-methoxy-2-
nitrophenyl)ethanone (8) 
 o-Hydroxy-6-nitrovanillone (7) (455 mg, 2.2 mmol) and K2CO3 (297 mg, 2.2 mmol) were 
added to a solution of 3 (1.0 g, 2.2 mmol) in DMF (6 mL). The mixture was stirred at 60°C overnight. 
The reaction mixture was poured into a solution of sat. NH4Cl (150 mL) and extracted with EtOAc 
three times and dried over Na2SO4. The solvent was evaporated under reduced pressure and the 
crude product was purified by flash chromatography (cyclohexane/EtOAc, 1:3) to yield the desired 
product 8 (830 mg, 64%). 1H NMR (400 MHz, DMSO-d6): δ 7.69 (s, 1H), 6.76 (s, 1H), 4.28 (m, 2H), 
3.96 (s, 3H), 3.92 (m, 2H), 3.74 (m, 2H), 3.69 – 3.62 (m, 18H), 3.56 (m, 2H), 3.53 (t, J = 6.8 Hz, 2H), 
3.45 (t, J = 6.8 Hz, 2H), 2.50 (s, 3H), 1.77 (m, 2H), 1.59 (m, 2H), 1.49 – 1.34 (m, 4H); 13C NMR (100.6 
MHz, DMSO-d6): δ 200.1, 154.4, 149.0, 138.3, 133.0, 108.9, 108.7, 71.2, 71.0, 70.7, 70.6, 70.1, 69.4, 
69.3, 56.7, 53.6, 45.1, 32.6, 30.4, 29.5, 26.7, 25.5; HRMS C27H45ClNO11 [M+H]+ calcd: 594.2676, 
found: 594.2664. 
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Preparation of 1-(4-((24-chloro-3,6,9,12,15,18-hexaoxatetracosyl)oxy)-5-methoxy-2-
nitrophenyl)ethanol (9) 
 Compound 8 (675 mg, 1.1 mmol) was dissolved in MeOH/Dioxane mixture (7 mL / 7 mL). 
NaBH4 (51 mg, 2.0 mmol) was added portionwise at 0°C. The mixture was stirred at rt for 2 h. Then, 
the mixture was poured into water, neutralized with a 1 M solution of HCl and extracted with CH2Cl2 
three times. The combined organic layers were dried over Na2SO4 and the solvent was evaporated 
under reduced pressure. The crude product was purified by flash chromatography (CH2Cl2/MeOH, 
20:1) to yield compound 9 (568 mg, 84%). 1H NMR (400 MHz, DMSO-d6): δ 7.61 (s, 1H), 7.29 (s, 1H), 
5.53 (q, J = 6.3 Hz, 1H), 4.21 (m, 2H), 3.95 (s, 3H), 3.88 (m, 2H), 3.70 (m, 2H), 3.59 – 3.66 (m, 18H), 
3.55 (m, 2H), 3.51 (m, 2H), 3.43 (m, 2H), 2.50 (s, 3H), 1.75 (m, 2H), 1.57 (m, 2H), 1.52 (d, J = 6.3 Hz, 
3H), 1.32 – 1.46 (m, 4H); 13C NMR (100.6 MHz, DMSO-d6): δ 153.4, 146.3, 138.9, 138.1, 109.1, 
108.6, 70.2, 70.0, 69.8, 69.5, 68.8, 68.4, 66.4, 56.0, 54.9, 45.3, 32.0, 29.1, 26.1, 25.2, 25.0; HRMS 
C27H47ClNO11Na [M+Na]+ calcd: 619.2730, found: 619.2724. 
 
 
Preparation of 1-(4-((24-chloro-3,6,9,12,15,18-hexaoxatetracosyl)oxy)-5-methoxy-2-
nitrophenyl)ethyl (4-(((2-amino-9H-purin-6-yl)oxy)methyl)benzyl)carbamate (MeNV-HaXS) 
 Compound 9 (829 mg, 1.4 mmol) was added slowly to a solution of bis p-nitrophenyl 
carbonate (423 mg, 1.4 mmol) in 10 mL of DMF at 0°C. Triethylamine (193 μl, 1.4 mmol) was added 
and the mixture was stirred at rt overnight. O6-aminomethylbenzylguanine (379 mg, 1.4 mmol) was 
added portionwise. The solution was stirred at 70°C for 6 h. The reaction was quenched with H2O and 
extracted with EtOAc three times. The combined organic layers were dried over Na2SO4 and the 
solvent was evaporated under reduced pressure. The crude product was purified by flash 
chromatography (CH2Cl2/MeOH, 20:1) to yield MeNV-HaXS (687 mg, 55%). 1H NMR (400 MHz, 
DMSO-d6): δ 7.66 (s, 1H), 7.43 (d, J = 7.9, 2H), 7.21 (d, J = 7.9, 2H), 7.14 (s, 1H), 6.28 (q, J = 6.5 Hz, 
1H), 5.51 (m, 2H), 4.14 – 4.31 (m, 5H), 3.80 – 3.86 (m, 6H), 3.68 – 3.70 (m, 2H), 3.50 – 3.64 (m, 
24H), 3.43 (t, J = 6.6 Hz, 2H), 1.69 – 1.74 (m, 2H), 1.59 (d, J = 6.5 Hz, 3H), 1.52 – 1.59 (m, 2H), 1.30 
– 1.46 (m, 4H); 13C NMR (100.6 MHz, DMSO-d6): δ 148.7, 141.0, 140.4, 129.7, 128.4, 110.8, 109.5, 
72.2, 71.8, 71.6, 71.5, 71.2, 70.7, 70.3, 70.1, 68.8, 56.9, 45.8, 45.1, 33.8, 30.6, 27.7, 26.5, 22.4; 
HRMS C41H59ClN7O13 [M+H]+ calcd: 892.3854, found: 892.3842. 
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4. Supplementary experiments and data 
 
Determination of the quantum yield of MeNV-HaXS at 360 nm: 
 The quantum yield (φ) of MeNV-HaXS was determined by dividing the reaction rate of the 
photolysis (r) by the number of photons entering the photoreactor per unit of time (quantum flow).  
 
     
φ       (1)
 
Determination of the quantum flow of the Lumos 43A photoreactor: 
 Ferrioxalate actinometry was used to determine the quantum flow of the Lumos 43A 
photoreactor (LED 360 nm lamp). To this end, potassium ferrioxalate (147.5 mg, 0.34 mmol) was 
dissolved in 40 mL water. 40 mL of 1 N sulfuric acid were added and the solution was further diluted 
to 50 mL with water. 3 mL of this solution was pipetted into the absorption cell and irradiated for a 
given time. 2 mL of the irradiated solution was mixed with 2 mL of a 5.6 mM aqueous o-
phenanthroline solution and 1 mL of a sodium acetate buffer. As reference 2 mL of non-irradiated 
ferrioxalate solution was treated with 2 mL of a 5.6 mM aqueous o-phenanthroline solution and 1 mL 
of a sodium acetate buffer. The 2 solutions were stored for 1 hour in absolute darkness prior to 
measure the absorbance of the solutions at 510 nm (Figure S1 A). The quantum flow was calculated 
using equation (2). 
 
Quantum flow [Einstein/s]
2
31
Vlt
VVA
⋅⋅⋅⋅
⋅⋅
εφ
   (2)

A = absorbance of the irradiated solution at 510 nm V1 = irradiated volume (3 mL) 
t = irradiation time in seconds V2 = used volume of V1 (2 mL) 
φ = quantum yield at the irradiation wavelength (1.26 at 360 nm) V3 = end volume (20 mL) 
ε = extinction coefficient of the complex at 510 nm l = thickness of the cell (1 cm) 
(1.11·104 L/Mol/cm) 
 
 The dose of photon emitted by the lamp was determined and plotted against time (Figure S1 
B). The slope of the regression line, corresponding to the quantum flow of the Lumos 43A 
photoreactor is 1.33·10-8 E/s or 4.79·10-5 E/h. 
 
Determination of the photolysis rate of MeNV-HaXS: 
 3 mL of a 0.5 M of a MeNV-HaXS in a DMSO/water (1:10) solution were transferred into a 
standard absorbance cell and irradiated in the Lumos 43A photoreactor at 360 nm for 1, 2, 3.5 and 5 
minutes. The conversion was determined by UPLC-MS by integration of the absorption peak of 
MeNV-HaXS. Disappearance of the MeNV-HaXS was plotted as a function of the time (Figure S1 C). 
The slope of the regression line corresponds to the rate constant (k). The reaction rate was calculated 
using equation (3). The reaction rate was quantified as 6·10-8 mol/min. 

             (3) 
 
 The reaction rate was quantified as 6·10-8 mol/min. Using equation (1) with the reaction rate 
6·10-8 mol/min and the quantum flow of 1.33·10-8 E/s, the photolysis quantum yield of MeNV-HaXS 
was calculated to be 0.075. 
  
Determination of the molar absorption coefficient of MeNV-HaXS at 360 nm 
 A 10-5 M solution of MeNV-HaXS in DMSO was recorded on a Perkin Elmer Lambda 40 
UV/Vis spectrometer using quartz standard absorption cells (l = 1cm) (Figure S1 D). The extinction 
coefficient at 360 nm was calculated using the Beer-Lambert law (4). 
 
               (4) 
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Figure S1: A) UV/Vis spectrum of ferrous o-phenanthroline complex formed after irradiation of 
Potassium ferrioxalate B) Dose of photons emitted by the lamp plotted against time to determine the 
quantum flow (E/s) of the Lumos 43A photoreactor (LED 360 nm lamp) C) Amount of MeNV-HaXS as 
determined with UPLC-MS plotted against time to determine the photolysis rate of MeNV-HaXS D) 
UV/Vis spectrum of MeNV-HaXS. 
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Figure S2: Cytosolic protein translocation to different cellular compartments: a) Giantin was used to 
target the Halo-RFP-Giantin to the Golgi, b) the CAAX box of K-Ras targeted SNAP-GFP-CAAX to 
the plasma membrane, c) Mito-SYFP-SNAP localized on mitochondria, d) the Rheb15-tagged Halo-
RFP-Rheb15 was localized on early and late endosomes, e) LAMP1 was on lysosomes, and f) LifeAct 
served as an anchor on the F-actin cytoskeleton. HeLa cells expressing the indicated organelle 
anchors and the indicated cytosolic cargo proteins were grown on 12 mm coverslips (Menzel), before 
they were incubated with MeNV-HAXS (37°C, 15 min), washed twice with PBS, and fixed with 4% p-
formaldehyde (PFA, in PBS), and mounted in Mowiol (Plüss-Stauffer) containing 1% propyl gallate 
(Sigma-Aldrich). Translocation of cytosolic Halo-RFP, Halo-mTq or Halo-RFP fusion proteins (cargo) 
to the respective anchors is documented. 
10
ht
tp
://
do
c.
re
ro
.c
h
 
 
Figure S3: Release of Golgi-trapped SNAP-mTFP1 protein after UV illumination. a) At t = –15 min, 
HeLa cells expressing SNAP-mTFP1 and Halo-RFP-Giantin were exposed to 5 µM HaXS8 (5 µM 
MeNV-HaXS see Figure 3, main part), which caused the translocation of cytosolic SNAP-mTFP1 to 
the Golgi (labeled as “before 377 nm”). SNAP-mTFP1 intensity was monitored within the indicated 
circular regions of interest by live cell microscopy. At t = 0 illumination with UV light using a standard 
DAPI filter set on a conventional fluorescence microscope (t = 20 sec, 377 ± 25 nm) was initiated for 
20 s, and cells are shown after illumination (after 377 nm). b) Quantification of mTFP1 fluorescence 
intensity of selected regions of interest (circles) at Golgi-derived vesicles (v) and in cytoplasm (c) 
before and after illumination as described in a) are shown (values represent means ± SEM, n = 10, 
error bars removed where smaller than symbols used). Curves obtained with MeNV-HaXS (see 
Figure 3) are shown in green. 
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Legends to movie files 
 
 
 
Movie S1: HeLa cells expressing SNAP-mTFP1 and Halo-RFP-Giantin (Golgi anchor) were exposed 
to 5 µM MeNV-HaXS (t = -15:00 min). MeNV-HaXS induced translocation of cytosolic SNAP-mTFP1 
to the Golgi as imaged by live cell microscopy is shown in Movie S1. UV illumination at t = 00:00 of a 
subset of vesicles with a scanning FRAP laser (area marked by white square, LASER) released 
anchored SNAP-mTFP1 into the cytosol. 
 
 
 
Movie S2: HeLa cells expressing SNAP-mTFP1 and Halo-RFP-Giantin were exposed to 5 µM MeNV-
HaXS. Illumination of cells starting at t = 00:00 (for 20s, DAPI excitation filter, see main text) released 
Golgi-anchored SNAP-mTFP1. 
 
 
 
Movie S3: HeLa cells expressing the nuclear NLS-CFP-SNAP probe and Halo-RFP-Giantin were 
exposed to 5 µM MeNV-HaXS. The MeNV-HaXS induced translocation of nuclear NLS-CFP-SNAP to 
the Golgi was monitored by live cell microscopy. Illumination of the cell body was initiated at t = 00:00 
(150 areas * 5 ms at 355 nm) using a scanning FRAP laser, leading to the immediate release of NLS-
CFP-SNAP from Golgi vesicles into the cytosol. The reimport into the nucleus displays slower kinetics 
due to processes controlled by the nuclear import machinery.  
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5. Spectra of intermediate compounds and MeNV-HaXS 
5a. 1H NMR and 13C NMR spectra 
 
Figure S4: 1H NMR spectrum of 2 (400 MHz, CD3OD) 
 
 
Figure S5: 13C NMR spectrum of 2 (100.6 MHz, CD3OD) 
 
13
ht
tp
://
do
c.
re
ro
.c
h
Figure S6: 1H NMR spectrum of 3 (400 MHz, CD3OD) 
 
Figure S7: 13C NMR spectrum of 3 (100.6 MHz, CD3OD) 
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Figure S8: 1H NMR spectrum of 5 (400 MHz, CDCl3) 
 
 
Figure S9: 13C NMR spectrum of 5 (100.6 MHz, CDCl3) 
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Figure S10: 1H NMR spectrum of 6 (400 MHz, CDCl3) 
 
 
Figure S11: 1H NMR spectrum of 6 (100.6 MHz, CDCl3) 
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Figure S12: 1H NMR spectrum of 7 (400 MHz, CDCl3) 
 
 
Figure S13: 13C NMR spectrum of 7 (100.6 MHz, CDCl3) 
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Figure S14: 1H NMR spectrum of 8 (400 MHz, DMSO-d6) 
 
 
Figure S15: 13C NMR spectrum of 8 (100.6 MHz, DMSO-d6) 
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Figure S16: 1H NMR spectrum of 9 (400 MHz, DMSO-d6) 
 
 
Figure S17: 13C NMR spectrum of 9 (400 MHz, DMSO-d6) 
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Figure S18: 1H NMR spectrum of MeNV-HaXS (400 MHz, DMSO-d6) 
 
 
Figure S19: 13C NMR spectrum of MeNV-HaXS (100.6 MHz, DMSO-d6) 
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5b. HRMS spectra  
 
Figure S20: HRMS spectrum of 5 
 
 
Figure S21: HRMS spectrum of 6 
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Figure S22: HRMS spectrum of 7 
 
 
Figure S23: HRMS spectrum of 8 
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Figure S24: HRMS spectrum of 9 
 
 
Figure S25: HRMS spectrum of MeNV-HaXS 
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